Trial intelligence / Profile preview

Saw Palmetto Extracts for Lower Urinary Tract Symptoms

NCT06266000Phase 4Completed

Sponsor
RDC Clinical
Start
Jun 2024
Primary completion
Jun 2025
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in lower urinary tract symptoms (LUTS) (3 arms), sponsored by RDC Clinical. Primary endpoints: Daily Urinary Frequency Log and International Prostate Symptom Score at Day 84. Started Jun 2024; status: completed.

02

Conditions

lower urinary tract symptoms (LUTS)

Beyond the preview

Go deeper on NCT06266000.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06266000.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call